Previous studies have identified eighteen patients with neurodevelopmental disorder harboring de novo variants in the human SHANK2 gene [15,16,17,18,19,20,21,22,23,24,25], and we identified three additional patients with de novo variants of SHANK2 in our clinical screening cohort. The gene discussed is SHANK2; the disease is neurodevelopmental disorder.